Physician profile
Benjamin Hawley
NPI 1295096832
$2,174.48
in general payments reported to CMS, 2019-2025
23 companies · $342 in 2025
The $342 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $416 · 2020: $160 · 2021: $472 · 2022: $372 · 2023: $166 · 2024: $247 · 2025: $342.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $721 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $721.16 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intersect Ent, INC. | $673.36 | 2019-2022 | |
| Medtronic, INC. | $278.11 | 2021-2022 | |
| Inspire Medical Systems, INC. | $200.73 | 2023-2025 | Inspire |
| Genzyme Corporation | $138.22 | 2022-2025 | |
| Glaxosmithkline, LLC. | $119.96 | 2019-2025 | Nucala |
| Acclarent, INC | $108.38 | 2019-2023 | Trudi Nav Cable |
| Aerin Medical INC. | $80.77 | 2024 | |
| Amgen INC. | $79.59 | 2025 | Tezspire |
| Medtronic USA, INC. | $78.98 | 2019 | |
| Hologic Sales and Service, LLC | $70.64 | 2023 | Coolseal Generator |
| Stryker Corporation | $53.32 | 2019-2020 | |
| Olympus America INC. | $50.43 | 2019-2023 | |
| Apria Healthcare LLC | $31.04 | 2021 | |
| Optinose US, INC. | $30.08 | 2020-2021 | |
| Kaleo, INC. | $28.97 | 2019-2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $25.59 | 2021 | |
| Davol INC. | $23.15 | 2021 | |
| Integra Lifesciences Corporation | $22.66 | 2025 | Inspira Air, Acclarent Aera, Trudi Probe |
| Smith+Nephew, INC. | $18.18 | 2020 | |
| Paratek Pharmaceuticals, INC. | $16.18 | 2025 | Xhance |
| Regeneron Healthcare Solutions, INC. | $16.11 | 2025 | Dupixent |
| Merck Sharp & Dohme LLC | $16.11 | 2023 | |
| Greer Laboratories, INC. | $13.92 | 2025 | Oralair |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Hawley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.